Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Scotiabank
BNS
$106B
| $41.9M | 0.02% |
591,005
+147,460
| +33% | +$9.75M |
|
602
Novanta
NOVT
$4.95B
| $41.7M | 0.02% |
236,629
+2,294
| +1% | +$383K |
|
603
Vontier
VNT
$4.55B
| $41.7M | 0.02% |
1,356,008
-427,277
| -24% | -$13.9M |
|
604
Republic Services
RSG
$67.5B
| $41.5M | 0.02% |
297,859
-184,515
| -38% | -$24.5M |
|
|
SAGE
605
DELISTED
Sage Therapeutics
SAGE
| $41.5M | 0.02% |
974,982
-76,011
| -7% | -$3.18M |
|
606
Synchrony
SYF
$24.5B
| $41.3M | 0.02% |
890,740
-2,311,409
| -72% | -$111M |
|
607
FB Financial Corp
FBK
$2.97B
| $41.3M | 0.02% |
942,460
-171,097
| -15% | -$7.67M |
|
|
VERV
608
DELISTED
Verve Therapeutics
VERV
| $41.2M | 0.02% |
1,162,796
+1,913
| +0.2% | +$80.4K |
|
609
Baker Hughes
BKR
$59.3B
| $41.1M | 0.02% |
1,707,108
+948,356
| +125% | +$23.4M |
|
|
BBL
610
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $40.9M | 0.02% |
684,322
+145,746
| +27% | +$7.95M |
|
|
DEN
611
DELISTED
Denbury Inc.
DEN
| $40.8M | 0.02% |
533,337
+528,293
| +10,474% | +$41.8M |
|
|
ICVX
612
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $40.8M | 0.02% |
+1,846,660
| New | +$47.7M |
|
|
VTYX
613
DELISTED
Ventyx Biosciences
VTYX
| $40.8M | 0.02% |
+2,166,532
| New | +$41.1M |
|
614
Axalta
AXTA
$7.47B
| $40.7M | 0.02% |
1,229,194
+121,287
| +11% | +$3.85M |
|
615
O'Reilly Automotive
ORLY
$75.5B
| $40.6M | 0.02% |
862,635
-149,115
| -15% | -$6.45M |
|
616
Watts Water Technologies
WTS
$11.2B
| $40.6M | 0.02% |
208,861
-62,317
| -23% | -$11.8M |
|
|
FOCS
617
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $40.4M | 0.02% |
677,258
+154,764
| +30% | +$9.63M |
|
618
Zimmer Biomet
ZBH
$18.7B
| $40.4M | 0.02% |
327,817
+285,323
| +671% | +$37.3M |
|
619
MongoDB
MDB
$26.4B
| $40.4M | 0.02% |
76,292
+62,505
| +453% | +$32M |
|
|
DISCK
620
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $39.9M | 0.02% |
1,741,180
-97,346
| -5% | -$2.34M |
|
|
SILK
621
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $39.9M | 0.02% |
935,398
-14,676
| -2% | -$734K |
|
622
Ralph Lauren
RL
$22.3B
| $39.7M | 0.02% |
334,064
-3,085
| -0.9% | -$371K |
|
623
Toro Company
TTC
$8.85B
| $39.1M | 0.02% |
391,721
+298,740
| +321% | +$29.8M |
|
624
Clorox
CLX
$12B
| $38.8M | 0.02% |
222,731
-61,459
| -22% | -$10.2M |
|
625
Stride
LRN
$4.15B
| $38.8M | 0.02% |
1,163,057
+4,240
| +0.4% | +$146K |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.